Skip to Main Content

Author Details

Mosepele Mosepele
University of Botswana
2004
67
17
Sarah J Ratcliffe (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36166405How Applicable Is the Single-Dose AMBITION Regimen for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis to High-Income Settings?Clin Infect Dis2023
37957535Pilot Test of Mopati, a Multi-Level Adherence Intervention for People Living with HIV and Their Treatment Partners in Botswana.Int J Behav Med2023
37857692Prevalence and control of hypertension in a high HIV-prevalence setting, insights from a population based study in Botswana.Sci Rep2023
37996881Standard of care in advanced HIV disease: review of HIV treatment guidelines in six sub-Saharan African countries.AIDS Res Ther2023
37991431Performance of CHROMagar ESBL media for the surveillance of extended-spectrum cephalosporin-resistant <i>Enterobacterales</i> (ESCrE) from rectal swabs in Botswana.J Med Microbiol2023
38093032Author Correction: Pilot Test of Mopati, a Multi-Level Adherence Intervention for People Living with HIV and Their Treatment Partners in Botswana.Int J Behav Med2023
37119524Near-complete genome of SARS-CoV-2 Delta variant of concern identified in a symptomatic dog (Canis lupus familiaris) in Botswana.Vet Med Sci2023
36989253Correction: Equity in clinical trials for HIV-associated cryptococcal meningitis: A systematic review of global representation and inclusion of patients and researchers.PLoS Negl Trop Dis2023
37406040Risk Factors for Community Colonization With Extended-Spectrum Cephalosporin-Resistant Enterobacterales (ESCrE) in Botswana: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.Clin Infect Dis2023
37405697Stigma and Social Determinants of Health Associated With Fidelity to Guideline-Concordant Therapy in Patients With Breast Cancer Living With and Without HIV in Botswana.Oncologist2023
36701614Association of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection With Maternal Mortality and Neonatal Birth Outcomes in Botswana by Human Immunodeficiency Virus Status.Obstet Gynecol2023
36821530Maternal biomarkers of endothelial dysfunction and pregnancy outcomes in women with and without HIV in Botswana.PLoS One2023
34494226Role of Support Reciprocity in HIV Viral Suppression Among People Living with HIV and Their Treatment Partners in Botswana.Int J Behav Med2022
35740421Reversal of CSF HIV-1 Escape during Treatment of HIV-Associated Cryptococcal Meningitis in Botswana.Biomedicines2022
36460970Prevalence of the metabolic syndrome and associated factors among inpatients with severe mental illness in Botswana: a cross-sectional study.BMC Cardiovasc Disord2022
36104670Public and outpatients' awareness of calling emergency medical services immediately by acute stroke in an upper middle-income country: a cross-sectional questionnaire study in greater Gaborone, Botswana.BMC Neurol2022
36322466High concordance in plasma and CSF HIV-1 drug resistance mutations despite high cases of CSF viral escape in individuals with HIV-associated cryptococcal meningitis in Botswana.J Antimicrob Chemother2022
36384807Economic evaluation of implementation science outcomes in low- and middle-income countries: a scoping review.Implement Sci2022
35320642Single-Dose Liposomal Amphotericin B Treatment for Cryptococcal Meningitis.N Engl J Med2022
35042229Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa.Nature2022
32876378Utility of CD4 count measurement in the era of universal antiretroviral therapy: an analysis of routine laboratory data in Botswana.HIV Med2021
33764233Identifying "What Matters Most" to Men in Botswana to Promote Resistance to HIV-Related Stigma.Qual Health Res2021
33833207Current co-morbidities burden in patients living with HIV in low- and middle-income countries.Curr Opin HIV AIDS2021
34905451HIV self-testing may overcome stigma and other barriers to HIV testing among higher-socioeconomic status men in Botswana: A qualitative study.Afr J AIDS Res2021
34485721Healthcare professionals' knowledge of modifiable stroke risk factors: A cross-sectional questionnaire survey in greater Gaborone, Botswana.eNeurologicalSci2021
34748576Feasibility of oral HIV self-testing in female sex workers in Gaborone, Botswana.PLoS One2021
34043617Equity in clinical trials for HIV-associated cryptococcal meningitis: A systematic review of global representation and inclusion of patients and researchers.PLoS Negl Trop Dis2021
33347842Modest reduction in adverse birth outcomes following the COVID-19 lockdown.Am J Obstet Gynecol2021
32550019Prevalence and Determinants of Hypertension Awareness, Treatment, and Control in Botswana: A Nationally Representative Population-Based Survey.Int J Hypertens2020
33298029Developing an interprofessional transition course to improve team-based HIV care for sub-Saharan Africa.BMC Med Educ2020
32716966Acceptability of oral HIV self-testing among female sex workers in Gaborone, Botswana.PLoS One2020
32884461May Measurement Month 2018: an analysis of blood pressure screening results from Botswana.Eur Heart J Suppl2020
32590438A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration.AIDS2020
32645164An Evaluation of Baseline Kidney Function in the REPRIEVE Trial of Pitavastatin in Human Immunodeficiency Virus.J Infect Dis2020
30642386Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.Trials2019
30168000Impact of Efavirenz Metabolism on Loss to Care in Older HIV+ Africans.Eur J Drug Metab Pharmacokinet2019
30940760AMBIsome Therapy Induction OptimisatioN (AMBITION): High dose AmBisome for cryptococcal meningitis induction therapy in sub-Saharan Africa: economic evaluation protocol for a randomised controlled trial-based equivalence study.BMJ Open2019
29435953Role of Noncommunicable Diseases (NCDs) in Resource-Limited Settings (RLS).Curr HIV/AIDS Rep2018
29804227Benefits and Risks of Statin Therapy in the HIV-Infected Population.Curr Infect Dis Rep2018
29855606Polymorphisms in cytochrome P450 are associated with extensive efavirenz pharmacokinetics and CNS toxicities in an HIV cohort in Botswana.Pharmacogenomics J2018
29894383Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana.AIDS2018
30488038High Mortality in HIV-Associated Cryptococcal Meningitis Patients Treated With Amphotericin B-Based Therapy Under Routine Care Conditions in Africa.Open Forum Infect Dis2018
30619912Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected Individuals.Open Forum Infect Dis2018
30470259AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.Trials2018
29587735Correction to: Strengthening medical training programmes by focusing on professional transitions: a national bridging programme to prepare medical school graduates for their role as medical interns in Botswana.BMC Med Educ2018
29771268HIV disease is associated with increased biomarkers of endothelial dysfunction despite viral suppression on long-term antiretroviral therapy in Botswana.Cardiovasc J Afr2018
29465627A Social Network Analysis of HIV Treatment Partners and Patient Viral Suppression in Botswana.J Acquir Immune Defic Syndr2018
27447841Effects of sex and alcohol use on antiretroviral therapy outcomes in Botswana: a cohort study.Addiction2017
28481785Brief Report: CYP2B6 516G&gt;T Minor Allele Protective of Late Virologic Failure in Efavirenz-Treated HIV-Infected Patients in Botswana.J Acquir Immune Defic Syndr2017
28235058Cardiovascular disease risk prediction by the American College of Cardiology (ACC)/American Heart Association (AHA) Atherosclerotic Cardiovascular Disease (ASCVD) risk score among HIV-infected patients in sub-Saharan Africa.PLoS One2017
  • 1 - 50 of 67

Recommended Authors

Maria Mazzitelli
Padua University Hospital
Career Start Year 2016
Number of shared co-authors 0
Adovich S Rivera
Kaiser Permanente Southern California
Career Start Year 2014
Number of shared co-authors 0
Onyema Ogbuagu
Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 0
Henry Evans
Columbia University Vagelos College of Physicians and Surgeons
Career Start Year 2013
Number of shared co-authors 0
Sara H Bares
University of Nebraska Medical Center
Career Start Year 2011
Number of shared co-authors 1
Zsofia Szep
College of Medicine, Drexel University
Career Start Year 2011
Number of shared co-authors 3
Katherine R Schafer
Wake Forest School of Medicine, University of North Carolina
Career Start Year 2010
Number of shared co-authors 0
Keri N Althoff
Department of Epidemiology and Johns Hopkins Bloomberg School of Public Health
Career Start Year 2009
Number of shared co-authors 0
Allison DeLong
School of Public Health, Brown University
Career Start Year 2007
Number of shared co-authors 1
Elizabeth D Lowenthal
Perelman School of Medicine, University of Pennsylvania
Career Start Year 2006
Number of shared co-authors 7
Moses Bateganya
U.S Centers for Disease Control and Prevention
Career Start Year 2003
Number of shared co-authors 1
Moses Massaquoi
The Fenway Institute
Career Start Year 2002
Number of shared co-authors 1
Edward J Mills
McMaster University
Career Start Year 2001
Number of shared co-authors 2
Matthias Cavassini
Lausanne University Hospital, University of Lausanne
Career Start Year 1999
Number of shared co-authors 0
Michael A Horberg
Kaiser Permanente Bernard J. Tyson School of Medicine
Career Start Year 1998
Number of shared co-authors 0
David A Wohl
The University of North Carolina School of Medicine
Career Start Year 1997
Number of shared co-authors 1
Laura Smeaton
Harvard TH Chan School of Public Health
Career Start Year 1996
Number of shared co-authors 1
Giovanni Guaraldi
University Hospital of Modena Policlinico, University of Modena and Reggio Emilia
Career Start Year 1995
Number of shared co-authors 1
Gregory D Kirk
Johns Hopkins Bloomberg School of Public Health
Career Start Year 1993
Number of shared co-authors 0
Elizabeth J Carter
Warren Alpert School of Medicine at Brown University
Career Start Year 1990
Number of shared co-authors 0
Kelly A Gebo
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1990
Number of shared co-authors 2
Ann E Kurth
Yale University
Career Start Year 1989
Number of shared co-authors 1
Judith S Currier
David Geffen School of Medicine, University of California los angeles
Career Start Year 1989
Number of shared co-authors 3
Amy C Justice
VA Connecticut Healthcare System
Career Start Year 1988
Number of shared co-authors 3
Carl J Fichtenbaum
University of Cincinnati
Career Start Year 1988
Number of shared co-authors 1
Susan Swindells
University of Nebraska Medical Center
Career Start Year 1987
Number of shared co-authors 0
Ian Frank
IF School of Medicine, University of Pennsylvania
Career Start Year 1987
Number of shared co-authors 6
Robert Colebunders
Global Health Institute, University of Antwerp
Career Start Year 1982
Number of shared co-authors 1
Peter Bacchetti
University of California San Francisco
Career Start Year 1981
Number of shared co-authors 0
Michael S Saag
University of Alabama at Birmingham
Career Start Year 1980
Number of shared co-authors 2

Collaborators

Robert Gross
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 13
Andrew P Steenhoff
Children's Hospital of Philadelphia
Co-authored papers 10
David R Boulware
University of Minnesota
Co-authored papers 6
Scarlett L Bellamy
Dornsife School of Public Health, Drexel University.
Co-authored papers 6
Athena F Zuppa
The Children's Hospital of Philadelphia, University of Pennsylvania
Co-authored papers 4
Richard Aplenc
Children's Hospital of Philadelphia
Co-authored papers 4
Marijana Vujkovic
Co-authored papers 4
Kathy Lawler
University of Tasmania
Co-authored papers 4
Esther Seloilwe
University of Botswana
Co-authored papers 4
Brian L Strom
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Co-authored papers 4
Sarah J Ratcliffe (CM4AI)
University of Virginia
Co-authored papers 3
Rudo Nthobatsang
Center for AIDS Research, University of Pennsylvania
Co-authored papers 2
Mark W Tenforde
Centers for Disease Control and Prevention
Co-authored papers 2
Ebbing Lautenbach
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 2
Katherine T Steele
Perelman School of Medicine, University of Pennsylvania Philadelphia
Co-authored papers 2
Billy Tsima
University of Botswana
Co-authored papers 2
Kealeboga Jeremiah
Monash Medical Centre
Co-authored papers 1
Pamela S Douglas
Duke Clinical Research Institute, Duke University
Co-authored papers 1
Mariska Davids
University of Pretoria
Co-authored papers 1
Sarah M Lyon
Hospital of the University of Pennsylvania
Co-authored papers 1
David J Hunter
The Kolling Institute, University of Sydney, and Royal North Shore Hospital
Co-authored papers 1
Verity Hill
Yale School of Public Health
Co-authored papers 1
Andrew Rambaut
Institute of Ecology and Evolution, University of Edinburgh
Co-authored papers 1
Sergei L Kosakovsky Pond
Co-authored papers 1
Frances K Barg
University of Pennsylvania, Perelman School of Medicine
Co-authored papers 1
Catherine L Cherry
University of Witwatersrand
Co-authored papers 1
James B Meigs
Co-authored papers 1
Thomas R Ten Have
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania.
Co-authored papers 1
Carrie L Kovarik
University of Pennsylvania
Co-authored papers 1
Ralph B D'Agostino
Co-authored papers 1
Release 1.2